The 9th European Breast Cancer Conference (EBCC-9), the largest Breast Cancer Conference outside the USA, will enable participants to implement the new findings into their daily practice, making a tangible difference for their patients. This will be the core focus of EBCC-9, in Glasgow, Scotland from 19 to 21 March, in 2014.

The 6th Lab-on-a-Chip European Congress will bring together leaders from both academia and industry to discuss innovative developments in this exciting field. Attention will also be given to some of the many applications of Labs-on-Chips, from the enhancement of life science research, to taking diagnostics to the point of need. Overall this track will provide an excellent snapshot of this rapidly growing field.

Lab-on-a-Chip World Congress, 12-13 September 2013, San Diego, CA, USA

CSL’s delegates, acting in MICROBIOMED project, attended the Congress.

This poster was showed at Mikrosystemtechnik Kongress in Aachen in October 2013. It describes the work done on the project by IWE1-Aachen partner, especially on the detection techniques being studied.

Authors: A. Buchenauer, J. Lazar, V.H. Nguyen and U. Schnakenberg (IWE1, Aachen) in collaboration with M. Bialon, D. Segun, C. Stein and C. Püttmann (EMI, Aachen) and W.T.V. Germeraad (AZM, Maastricht)

A poster was showed at the 7th International Conference on Microtechnologies in Medicine and Biology, this spring in Marina Del Ray. It describes the work done on the project by IWE1-Aachen, EMI-Aachen and AZM-Maastricht partner, especially the study carried out on plasmonic flow-through biosensor.

Authors: A. Buchenauer (IWE1, Aachen), M. Bialon (EMI, Aachen), D. Segun (EMI, Aachen), W.T.V. Germeraad (AZM, Maastricht), and U. Schnakenberg (IWE1, Aachen)

A poster was showed at the 7th International Conference on Microtechnologies in Medicine and Biology, this spring in Marina Del Ray. It describes the work done on the project by IWE1-Aachen, EMI-Aachen and AZM-Maastricht partner, especially the study carried out impedance detection technique.

Authors: J. Lazar (IWE1, Aachen), A. Buchenauer (IWE1, Aachen), M. Bialon (EMI, Aachen), D. Segun1, W.T.V. Germeraad2, and U. Schnakenberg1

The Mikrosystemtechnik Kongress 2013, was held in Aachen on the 14th, 15th and 16th of October. Tis congress on microsystems gathered more than 800 experts from the industry and research in the fields of electronic- and microsystems. It focused on the state of the art both in Germany and in the world.

Breast cancer is the most common cancer in women worldwide. According to estimates, nearly 75.000 new cases occurred 2012 in Germany (Robert-Koch-Institute). For the improvement of the early detection of breast cancer the Interreg IV-A project MICROBIOMED (MICROtechnologies for BIOMEDical applications) was funded. The aim is to develop an antibody-based bioassay, which will later be integrated into a biochip system to achieve a simple and quick method for an early detection.

Breast cancer is with more than 1.3 million new cases per year the most common type of cancer in women worldwide. In contrast, men are only less than 1% affected by this disease. In addition to the generally used methods of breast-cancer diagnosis like palpation, mammography, ultrasound, magnetic resonance imaging and biopsy, there are only a few tools available which indicate (early) breast cancer on the molecular level of the disease like Theros H/ISM and MGISM (bioTheranostics), Mammaprint™ (Agendia) or Oncotype DX® (GenomicHealth).

The aim of the Microbiomed project is to develop a lab-on-a-chip system for the detection of breast cancer at an early stage. For this purpose cancer cell markers are being selected and a combination of these will be applied in different technical set-ups.

Pages